E-DRUG: Evergreening patents: Industry response to India's patent law (2)
-----------------------------------------------------------------
Hi,
We would like to see India protecting the interests of its population more often, like this.
The comment that "In view of this recent decision, pharmaceutical and
biotechnology companies are undoubtedly re-evaluating their foreign
patent strategies" should not shake the resolve of pro-people governments to go for working in the interest of its population.
Prof Dr Vijay Thawani,
India.
"Vijay Thawani" <vijaythawani@rediffmail.com>